Kerecis Introduces its Fish-Skin Wound Treatment to the Asian Market at Major Medical Congress Read More
Comparative Study at a Podiatrist Facility in Indiana Estimates $65,000 Savings from Using Omega3-Rich Fish Skin for Diabetic Wound Treatment Read More
Kerecis Wound-Treatment Product with Omega3 Fish Skin Now Eligible for Medicare Reimbursement in 45 States Read More
FDA Clears Omega3-rich Fish Skin for Surgical Applications. Device Cleared for Bariatric, Gastric and Colorectal Surgeries Read More
Kerecis Fish Skin Wound Treatment Available for the VA and Other Government Agencies. Listed on the Federal Supply Schedule (FSS) Read More
Kerecis Fish-Skin Wound Treatment Now Eligible for Reimbursement in North Carolina, South Carolina, Virginia and West Virginia Coverage Provided by Medicare Administrative Contractor Palmetto GBA Read More
Application of Fish Skin to Open Wounds Improves Healing High-Impact Trial Results of Fish Skin Wound Treatment Presented at Major European Wound Conference Read More
High-Impact Trial Results of Fish Skin Wound Treatment to Be Presented at SAWC Conference Multiple Poster Abstracts Demonstrate Efficacy of Fish Skin Wound Treatment When Compared to Alternative Technologies Read More
Kerecis Fish Skin Wound Treatment to be Available for U.S. Military Veterans Will be listed on the Federal Supply Schedule (FSS) through MellingMedical Read More
Kerecis Omega3 Fish Skin Wound Grafts Recruit Significantly More Cells than a Leading Amnion Membrane Wound Treatment Brand Read More
Studies on the Kerecis Fish Skin Graft Show that the Product Recruits Stem Cells and Closes Wounds Significantly Faster than the Leading Competitive Product Read More
